The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
Open accessAbstract
To test the hypothesis that obesity/insulin resistance impairs both endothelium-dependent vasodilation and insulin-mediated augmentation of endothelium-dependent vasodilation, we studied leg blood flow (LBF) responses to graded intrafemoral artery infusions of methacholine chloride (MCh) or sodium nitroprusside (SNP) during saline infusion and euglycemic hyperinsulinemia in lean insulin-sensitive controls (C), in obese insulin-resistant subjects (OB), and in subjects with non-insulin-dependent diabetes mellitus (NIDDM). MCh induced increments in LBF were approximately 40% and 55% lower in OB and NIDDM, respectively, as compared with C (P < 0.05). Euglycemic hyperinsulinemia augmented the LBF response to MCh by - 50% in C (P < 0.05 vs saline) but not in OB and NIDDM. SNP caused comparable increments in LBF in all groups. Regression analysis revealed a significant inverse correlation between the maximal LBF change in response to MCh and body fat content. Thus, obesity/insulin resistance is associated with (a) blunted endothelium-dependent, but normal endothelium-independent vasodilation and (b) failure of euglycemic hyperinsulinemia to augment endothelium-dependent vasodilation. Therefore, obese/insulin-resistant subjects are characterized by endothelial dysfunction and endothelial resistance to insulin's effect on enhancement of endothelium-dependent vasodilation. This endothelial dysfunction could contribute to the increased risk of atherosclerosis in obese insulin-resistant subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, IR per se has a direct impact on endothelial function, distinct from effects related to unfavorable changes in lipid composition or blood pressure (9).”
From Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus (2001) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,366
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. S., & Baron, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,216
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11367.x · Cited by 1,158
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,117
Flagged first, then by citations
Research works printed but not linked: 1
- Brozek, J., and A. Henschel. 1961. Techniques for measuring body com- position: proceedings of a conference. In Conference on Techniques for Mea- suring Body Composition. National Academy of Sciences, National Research Council. Washington DC. 78-89.
Cited by
Sorted by citations
Items 701–800 of 1,001
Wohlin, M. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00283-1 · Cited by 40
“Insulin sensitivity is also associated with endothelial release of nitric oxide (NO) [26].”
BackgroundManzoor, S., Ganie, M. A., Amin, S., Shah, Z. A., Bhat, I. A., Yousuf, S. D., Jeelani, H., Kawa, I. A., Fatima, Q., & Rashid, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-46644-4 · Cited by 40
Prediction of Preeclampsia: Can It Be Achieved?
Farag, K., Hassan, I., & Ledger, W. J. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200406000-00025 · Cited by 39
“Insulin resistance is associated with impaired fibrinolysis (80), blunted endothelium-dependent vasodilatation (81), reduced prostacyclin (PGI2) production, increased thromboxane (TxA2) production, increased coagulation, and platelet activation (82).”
BackgroundEndothelial dysfunction in human diabetes
Mäkimattila, S., & Yki‐Järvinen, H. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0054-x · Cited by 40
“SNP NS — — Steinberg et al. [ 49 ] 10/10 Brachial MCh”
BackgroundMizuno, T., Matsui, H., Imamura, A., Numaguchi, Y., Sakai, K., Murohara, T., & Okumura, K. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.10.035 · Cited by 40
Obesity Affects Myocardial Vasoreactivity and Coronary Flow Response to Insulin
Sundell, J., Laine, H. K., Luotolahti, M., Kalliokoski, K. K., Raitakari, O. T., Nuutila, P., & Knuuti, J. M. (2002) · Obesity Research · doi:10.1038/oby.2002.84 · Cited by 40
Imidazoline Antihypertensive Drugs: Selective I1‐Imidazoline Receptors Activation
Nikolic, K. M., & Agbaba, D. D. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00269.x · Cited by 39
“Hypertension is often observed as part of a more complex combination of diseases, such as obesity, hyperlipidemia, and hyperinsulinemia [82].”
BackgroundAdiponectin Predicts Insulin Resistance But Not Endothelial Function in Young, Healthy Adolescents
Singhal, A., Jamieson, N. B., Fewtrell, M. S., Deanfield, J. E., Lucas, A., & Sattar, N. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0131 · Cited by 39
Vascular Response to Angiotensin II in Upper Body Obesity
Nielsen, S., Halliwill, J. R., Joyner, M. J., & Jensen, M. D. (2004) · Hypertension · doi:10.1161/01.hyp.0000142111.67601.6b · Cited by 40
Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function
Bohlen, H. G., & Nase, G. P. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00019.2002 · Cited by 37
“In obese humans, nearly normal to only mild depression of endothelium-dependent vasodilation to cholinergic agents has been demonstrated in the arm (24, 26) and leg (1, 29) vasculatures, plus vascular responses to nitroprusside were essentially normal in Fig.”
BackgroundSummers, L. K. M., Samra, J. S., & Frayn, K. N. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00172-0 · Cited by 39
“Obese and insulin resistant human subjects are characterised by endothelial dysfunction and resistance to the effect of insulin on enhancement of endotheliumdependent vasodilation [16].”
BackgroundImprovement of Endothelial Dysfunction in Acromegaly after Transsphenoidal Surgery
Sakai, H., Tsuchiya, K., Nakayama, C., Iwashima, F., Izumiyama, H., Doi, M., Yoshimoto, T., TSUJINO, M., Yamada, S., & Hirata, Y. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-125 · Cited by 38
“This finding is consistent with a previous study showing that insulin resistance and hyperinsulinemia are independent predictors for decreased endothelium-dependent vasodilatation [30].”
ResultVascular Dysfunction in Diabetes and Obesity: Focus on TRP Channels
Moraes, R. D. A., Webb, R. C., & Silva, D. F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.645109 · Cited by 38
Jawa, A., Nachimuthu, S., Pendergrass, M. L., Asnani, S., & Fonseca, V. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1632 · Cited by 38
“Endothelial dysfunction has been associated with several disease states, including obesity (24), diabetes mellitus (25), and hypertension (26).”
BackgroundHigher carotid‐radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes
McEleavy, O. D., McCallum, R. W., Petrie, J. R., SMALL, M. P., Connell, J. M. C., Sattar, N. A., & Cleland, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01127.x · Cited by 38
Rosiglitazone Prevents Free Fatty Acid-Induced Vascular Endothelial Dysfunction
Mittermayer, F., Schaller, G., Pleiner, J., Krzyżanowska, K., Kapiotis, S., Roden, M., & Wolzt, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2130 · Cited by 38
Shankar, S. S., & Dubé, M. P. (2004) · Cardiovascular Toxicology · doi:10.1385/ct:4:3:261 · Cited by 38
“However, studies from our institution (33,34) and others (35) show that periphTable 1 Approved Antiretroviral Drugs”
BackgroundEvaluation of endothelial function in women with polycystic ovary syndrome
Löwenstein, L., Damti, A., Pillar, G., Shott, S., & Blumenfeld, Z. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.02.011 · Cited by 39
“Insulin resistance may play an early role in the development of endothelial damage [4,5], which is regarded as an early feature of atherosclerosis [4].”
BackgroundResultInfluentialInsulin Improves Alveolar-Capillary Membrane Gas Conductance in Type 2 Diabetes
Guazzi, M., Oreglia, I., & Guazzi, M. D. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1802 · Cited by 38
Cytochrome P450 Activity and Endothelial Dysfunction in Insulin Resistance
Katakam, P. V. G., Hoenig, M. E., Ujhelyi, M. R., & Miller, A. W. (2000) · Journal of Vascular Research · doi:10.1159/000025759 · Cited by 38
“Although the mechanism(s) that link insulin resistance and vascular dysfunction still remain unclear, impairment of endothelial function has been proposed as one potential mechanism. This hypothesis is supported by studies in both insulin-resistant human subjects [”
ResultProlonged treatment with angiotensin 1–7 improves endothelial function in diet-induced obesity
Beyer, A. M., Guo, D.-F., & Rahmouni, K. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835ecbe5 · Cited by 37
Boustany, C., Gong, M. C., Akers, W. S., Guo, Z., & Cassis, L. A. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803426 · Cited by 35
Tsuchiya, K., Nakayama, C., Iwashima, F., Sakai, H., Izumiyama, H., Doi, M., & Hirata, Y. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e525 · Cited by 37
Koshimura, K., Tanaka, J., Murakami, Y., & Kato, Y. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00016-0 · Cited by 36
“In addition to the glucose-induced neurotoxic effect shown in the present study, NO is reported to be involved in insulin secretion from b cells (Coiro et al., 1997; Henningsson and Lundquist, 1998) or insulin resistance (Steinberg et al., 1996; Shinozaki et al., 1999; Kurioka et al., 2000).”
Obesity is associated with impaired endothelial function in the postprandial state
Jonk, A. M., Houben, A. J. H. M., Schaper, N. C., de Leeuw, P. W., Serné, E. H., Smulders, Y. M., & Stehouwer, C. D. A. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.08.006 · Cited by 36
Taguchi, K., Matsumoto, T., Kamata, K., & Kobayashi, T. (2012) · Endocrinology · doi:10.1210/en.2012-1101 · Cited by 36
Vascular Dysfunction in Horses with Endocrinopathic Laminitis
Morgan, R., Keen, J., Walker, B. R., & Hadoke, P. W. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163815 · Cited by 36
“Hyperinsulinaemia can result in endothelial cell dysfunction, specifically blunting vasodilatory responses, as well as endothelial resistance to insulin- induced enhancement of vasodilation [54].”
BackgroundHoddy, K. K., Bhutani, S., Phillips, S. A., & Varady, K. A. (2016) · Nutrition and Healthy Aging · doi:10.3233/nha-1611 · Cited by 36
“Keywords: Alternate day fasting, insulin resistance, endothelial function, adipokines, weight loss, coronary heart disease”
BackgroundEffect of salt-loading on blood pressure, insulin sensitivity and limb blood flow in normal subjects
Foo, M. W. Y., Denver, A. E., Coppack, S. W., & Yudkin, J. S. (1998) · Clinical Science · doi:10.1042/cs0950157 · Cited by 36
Wiberg, B., Sundström, J., Zethelius, B., & Lind, L. (2008) · Diabetologia · doi:10.1007/s00125-008-1171-0 · Cited by 36
“Second, elevated plasma non-esterified fatty acids are known to aggravate the insulin-resistant state both in skeletal muscle and in the liver [16], and also to have direct vascular effects such as promotion of endothelial dysfunction [17] and elevation of blood pressure [18], the most well-established risk factor for…”
BackgroundVessières, E., de Chantemèle, E. J. B., Toutain, B., Guihot, A., Jardel, A., Loufrani, L., & Henrion, D. (2010) · Frontiers in Physiology · doi:10.3389/fphys.2010.00145 · Cited by 36
Leptin Increases Blood Pressure and Markers of Endothelial Activation during Pregnancy in Rats
Alshaikhli, H., Omar, E., Froemming, G. R. A., & Singh, H. J. (2013) · BioMed Research International · doi:10.1155/2013/298401 · Cited by 36
de Oliveira, A. P., Calderon, I. D. M. P., Costa, R. A., Roscani, M. G., Magalhães, C. G., & Borges, V. T. M. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114563302 · Cited by 36
THP-1 Macrophages and SGBS Adipocytes ? A New Human in vitro Model System of Inflamed Adipose Tissue
Keuper, M., Dzyakanchuk, A. A., Amrein, K. E., Wabitsch, M., & Fischer‐Posovszky, P. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00089 · Cited by 36
“Obesity is associated with endothelial dysfunction, a key early event in the initiation and progression of atherosclerosis (Steinberg et al., 1996).”
BackgroundMcCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.042 · Cited by 35
“042 syndrome and diabetes [4,5]; in these syndromes, the ability of insulin-resistant adipocytes to store and retain FFAs is compromised, leading to sustained elevations in serum FFAs and a failure to suppress FFAs appropriately following meals.”
BackgroundInduction of NAFLD with Increased Risk of Obesity and Chronic Diseases in Developed Countries
Martins, I. J. (2014) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2014.44011 · Cited by 36
“The control of chronic diseases induced by EDC disturbances depends on diets and anti-obese drugs that target Sirt1/PXR disorders (Figure 1) that are linked to the induction of obesity, cardiovascular disease and various diseases that involve the chronic endothelial injury hypothesis [129]-[136].”
BackgroundEffect of Weight Reduction on Cardiovascular Risk Factors and CD34-positive Cells in Circulation
Mikirova, N. A., Casciari, J. J., Hunninghake, R., & Beezley, M. M. (2011) · International Journal of Medical Sciences · doi:10.7150/ijms.8.445 · Cited by 35
“All these abnormalities create a state of constant and progressive damage to the vascular wall, manifested by a low-grade progressive inflammatory process and endothelial dysfunction [31, 32].”
BackgroundEl-Kader, S. M. A., & Al-Jiffri, O. H. (2018) · African Health Sciences · doi:10.4314/ahs.v18i4.5 · Cited by 37
Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection
Otamas, A., Grant, P. J., & Ajjan, R. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120920582 · Cited by 39
Brown, O. I., Bridge, K., & Kearney, M. T. (2021) · Cells · doi:10.3390/cells10092315 · Cited by 36
Sanip, Z., Ariffin, F. D., Al-Tahami, B. A. M., Sulaiman, W. A. W., & Rasool, A. H. G. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.05.002 · Cited by 37
Close Relationship of Abnormal Glucose Tolerance With Endothelial Dysfunction in Hypertension
Tomiyama, H., Kimura, Y., Okazaki, R., Kushiro, T., Abe, M., Kuwabara, Y., Yoshida, H., Kuwata, S., Kinouchi, T., & Doba, N. (2000) · Hypertension · doi:10.1161/01.hyp.36.2.245 · Cited by 35
Rossi, M. C., Nicolucci, A., Pellegrini, F., Comaschi, M., Ceriello, A., Cucinotta, D., Giorda, C. B., Pomili, B., Valentini, U., Vespasiani, G., et al. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.02.013 · Cited by 36
Insulin resistance and the endothelium
Quiñones, M. J., Nicholas, S. B., & Lyon, C. J. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0018-z · Cited by 35
“Obesity is a risk factor for IR, T2D, and atherosclerosis and it is associated with endothelial abnormalities [ 29 ].”
BackgroundEsposito, K., Nicoletti, G., & Giugliano, D. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345092 · Cited by 35
Cardiovascular consequences of the obesity pandemic: need for action
Barton, M., & Furrer, J. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.11.1757 · Cited by 36
“marker of vascular integrity and a predictor of cardiovascular and cerebrovascular death [16,17], is defective in humans with atherosclerosis [18] as well as in obese humans [19-22] and animals [23,24].”
BackgroundHemostatic abnormalities associated with obesity and the metabolic syndrome
Reaven, G. M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01277.x · Cited by 35
The effects of aging and activity on muscle blood flow
Olive, J. L., DeVan, A. E., & McCully, K. K. (2002) · Dynamic Medicine · doi:10.1186/1476-5918-1-2 · Cited by 35
Activation of the endothelin system in insulin resistance
Irving, J. (2001) · QJM · doi:10.1093/qjmed/94.6.321 · Cited by 35
Relation of Plasma Insulin Levels to Forearm Flow-Mediated Dilatation in Healthy Volunteers
Ardigò, D., Franzini, L., Valtueña, S., Monti, L. D., Reaven, G. M., & Zavaroni, I. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.047 · Cited by 35
Acute Endothelium-Mediated Vasodilation Is Not Impaired at the Onset of Diabetes
Brands, M. W., & Fitzgerald, S. M. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.541 · Cited by 35
Vasoreactivity is rapidly improved in obese subjects after gastric bypass surgery
Lind, L., Zethelius, B., Sundbom, M., Engström, B. E., & Karlsson, F. A. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.188 · Cited by 34
Kveiborg, B., Hermann, T. S., Major‐Pedersen, A., Christiansen, B., Rask‐Madsen, C., Raunsø, J., Køber, L., Torp-Pedersen, C. T., & Domínguez, H. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-21 · Cited by 34
“Diabetes and insulin resistance are associated with endothelial dysfunction [7] as well as reduced insulin sensitivity of the endothelium - reduced insulin-stimulated endothelial function [8,9].”
BackgroundHarnessing polyphenol power by targeting eNOS for vascular diseases
Das, M., Devi, K. P., Belwal, T., Devkota, H. P., Tewari, D., Sahebnasagh, A., Nabavi, S. F., Kashani, H. R. K., Rasekhian, M., Xu, S., et al. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1971153 · Cited by 35
Insulin resistance in penile arteries from a rat model of metabolic syndrome
Contreras, C., Sánchez, A., Martínez, M. P., Raposo, R., Climent, B., García‐Sacristán, A., Benedito, S., & Prieto, D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00825.x · Cited by 34
“…men and patients with type 2 diabetes, the insulin-mediated activation of the PI3K/Akt pathway underlying both the metabolic and the vascular actions of the hormone is impaired, and endothelial dysfunction and blunted vasodilatation have been reported (Steinberg et al., 1996; Cusi et al., 2000).”
BackgroundInfluentialMukhopadhyay, S., & Mukherjee, T. K. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.03.010 · Cited by 34
KATP‐mediated Vasodilation is Impaired in Obese Zucker Rats
Hodnett, B. L., Xiang, L., Dearman, J., Carter, C. B., & Hester, R. L. (2008) · Microcirculation · doi:10.1080/10739680801942240 · Cited by 34
“accompanying attenuated release of endotheliumderived regulators of blood flow [48].”
BackgroundeNOS haplotype associated with hypertension in obese children and adolescents
Souza-Costa, D. C., Belo, V. D. A., Silva, P. S., Metzger, I. F., Lanna, C. M. M., Machado, M. A., & Tanus-Santos, J. E. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.146 · Cited by 34
Rajapakse, N. W., Chong, A. L., Zhang, W., & Kaye, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061840 · Cited by 35
Wheatcroft, S. B., Kearney, M. T., Shah, A. M., Grieve, D., Williams, I. L., MIELL, J. P., & Crossey, P. A. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2075 · Cited by 34
The effect of high glucose on NO and O2− through endothelial GTPCH1 and NADPH oxidase
qungfang, D., Hayashi, T., Packiasamy, A. J., Miyazaki, A., Fukatsu, A., Shiraishi, H., Nomura, T., & Iguchi, A. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.005 · Cited by 34
FFAs: Do they play a role in vascular disease in the insulin resistance syndrome?
Shankar, S. S., & Steinberg, H. O. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0064-6 · Cited by 34
“Subsequently, many more metabolic and vascular abnormalities have been described, including impaired endothelial function [7], increased levels of the endogenous inhibitor of endothelial nitric oxide synthase (eNOS), elevated plasminogen activator inhibitor [8], C-reactive protein (CRP), and possibly increased oxidati…”
BackgroundDiabetes mellitus, inflamación y aterosclerosis coronaria: perspectiva actual y futura
Sánchez‐Recalde, Á., & Kaski, J. C. (2001) · Revista Española de Cardiología · doi:10.1016/s0300-8932(01)76390-7 · Cited by 35
Effects of metformin on endothelial health and erectile dysfunction
Patel, J. P., Lee, E. H., Mena, C. I., & Walker, C. N. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2017.03.52 · Cited by 33
“Insulin resistance drives ED though complex mechanisms involving endothelial dysfunction, impaired vasodilatation, increased sympathetic tone, inflammation, and atherosclerosis (5-7).”
BackgroundShi, X., Wang, S., Luan, H., Tuerhong, D., Lin, Y., Liang, J., Xiong, Y., Rui, L., & Wu, F. (2019) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x19500058 · Cited by 33
Alshaikhli, H., Froemming, G. R. A., Omar, E., & Singh, H. J. (2014) · Reproductive Toxicology · doi:10.1016/j.reprotox.2014.08.006 · Cited by 33
Impact of the metabolic syndrome on subcutaneous microcirculation in obese patients
Grassi, G. M., Seravalle, G., Brambilla, G., Facchetti, R., Bolla, G. B., Mozzi, E., & Mancia, G. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833af3c9 · Cited by 33
Reproductive Sequelae of Diabetes in Male Patients
Gaunay, G. S., Nagler, H. M., & Stember, D. S. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.003 · Cited by 33
Meal-Related Increases in Microvascular Vasomotion Are Impaired in Obese Individuals
Jonk, A. M., Houben, A. J. H. M., Schaper, N. C., de Leeuw, P. W., Serné, E. H., Smulders, Y. M., & Stehouwer, C. D. A. (2011) · Diabetes Care · doi:10.2337/dc11-s240 · Cited by 33
“Obese individuals are characterized by muscle capillary rarefaction (24) and a disturbed balance of NO and ET-1 in the muscle microcirculation (25,26).”
BackgroundRossi, M., Nannipieri, M., Anselmino, M., Pesce, M., Muscelli, E., Santoro, G., & Ferrannini, E. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0286-9 · Cited by 33
“Furthermore, some authors suggest that microvascular dysfunction may contribute to arterial hypertension [3] and insulin resistance [3, 4, 7], which importantly concur to increased cardiovascular risk in obese patients.”
BackgroundAfşar, B., Sezer, S., Elsürer, R., & Özdemir, F. N. (2007) · Blood Pressure Monitoring · doi:10.1097/mbp.0b013e3280b08379 · Cited by 32
Targeting adiponectin for cardioprotection
Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.573 · Cited by 33
“These findings suggest that the adiponectin-AMPK regulatory axis protects against in the development of vascular insufficiency and endothelial cell dysfunction that is prevalent in obese individuals [60-63].”
BackgroundVascular Structure and Function in Women
Olson, T. P., Schmitz, K. H., Leon, A. S., & Dengel, D. R. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.02.006 · Cited by 33
Management of the patient with diabetes mellitus and myocardial infarction: clinical trials update
Klein, L., & Gheorghiade, M. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.020 · Cited by 33
The 1st World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.602 · Cited by 33
[Correlations of insulin resistance and neoplasms].
Suba, Z., & Ujpál, M. (2006) · PubMed · Cited by 33
Dabelea, D. (2003) · Springer eBooks · doi:10.1007/978-3-642-59352-9_2 · Cited by 34
Daniele, A., Lucas, S. J. E., & Rendeiro, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.998380 · Cited by 43
“…of vascularrelated conditions including hypertension (Tarray et al., 2014), atherosclerosis (Semenkovich 2006), and endothelial dysfunction (Steinberg et al., 1996), and insulin plays an important role in conduit arteries compliance, modulation of blood flow and relaxation of resistance…”
BackgroundGatenby, V. K., & Kearney, M. T. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.528930 · Cited by 32
“A range of other studies has provided compelling evidence supporting a strong association between insulin resistance and NO bioavailability in humans [41-44].”
Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women
Motivala, A. A., Rose, P. A., Kim, H. M., Smith, Y. R., Bartnik, C. M., Brook, R. D., Muzik, O., & Duvernoy, C. S. (2008) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2008.02.020 · Cited by 31
Mohiyiddeen, L., Watson, A., Apostolopoulos, N. V., Berry, R. A., Alexandraki, K., & Jude, E. B. (2013) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2012.745839 · Cited by 32
“Insulin resistance has been suggested to have a central role in the development of endothelial damage (Steinberg et al. 1996).”
BackgroundInsulin resistance in vascular endothelial cells promotes intestinal tumour formation
Wang, X., Häring, M.-F., Rathjen, T., Lockhart, S. M., Sørensen, D., Ussar, S., Rasmussen, L. M., Bertagnolli, M. M., Kahn, C. R., & Rask‐Madsen, C. (2017) · Oncogene · doi:10.1038/onc.2017.107 · Cited by 32
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
Mason, H. D., Colao, A., Blume‐Peytavi, U., Rice, S., Qureshi, A., Pellatt, L. J., Orio, F., & Atkin, S. L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03329.x · Cited by 33
Byers, B. D., Betancourt, A., Lu, F., Hankins, G. D. V., Longo, M., Saade, G. R., & Bytautiene, E. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.01.044 · Cited by 32
Lin, L., Lee, W.-J., Shen, H.-N., Yang, W., Pai, N.-H., Su, T., & Liau, C. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.033 · Cited by 32
Shinozaki, K., Kashiwagi, A., Masada, M., & Okamura, T. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.91.187 · Cited by 32
Hypertension alone or related to the metabolic syndrome in postmenopausal women
Nuzzo, A., Rossi, R., & Modena, M. G. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.147 · Cited by 32
The Epidemic of Coronary Heart Disease in South Asian Populations: Causes and Consequences
Bhopal, R. S., & Patel, K. (2004) · ERA · Cited by 32
Watarai, T., Yamasaki, Y., IKEDA, M., Kubota, M., Kodama, M., Tsujino, T., Kishimoto, M., Kawamori, R., & Hori, M. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.629 · Cited by 32
Renal damage in the metabolic syndrome (MetSx): Disorders implicated
Joyce, T., Chirino, Y. I., Martínez‐Tagüeña, N., & Pedraza‐Chaverrí, J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.032 · Cited by 30
Regional Heterogeneity of Functional Changes in Conduit Arteries After High‐fat Diet
Bhattacharya, I., Mundy, A. L., Widmer, C. C., Kretz, M., & Barton, M. (2008) · Obesity · doi:10.1038/oby.2007.111 · Cited by 31
Vibration Disrupts Vascular Function in a Model of Metabolic Syndrome
Krajnak, K., Waugh, S., Johnson, C., Miller, R., & Kiedrowski, M. R. (2009) · Industrial Health · doi:10.2486/indhealth.47.533 · Cited by 31
El‐Bassossy, H. M., Dsokey, N., & Fahmy, A. (2014) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2014.945109 · Cited by 31
“Numerous previous studies suggested a strong association between insulin resistance and endothelial dysfunction (Steinberg et al., 1996).”
BackgroundKodaman, P. H., & Dulęba, A. J. (2008) · Drugs · doi:10.2165/00003495-200868130-00001 · Cited by 31
“[52] PCOS to endothelial dysfunction,[44-46] and obese, insulin-resistant women with PCOS have metabolic 1.”
Postprandial Vascular Reactivity in Obese and Normal Weight Young Adults
Ayer, J. G., Harmer, J. A., Steinbeck, K. S., & Celermajer, D. S. (2009) · Obesity · doi:10.1038/oby.2009.331 · Cited by 31
“Although differences in vascular function between obese and normal weight subjects have been demonstrated in the fasting state (19,20), postprandial vascular reactivity has not been well studied in obese subjects.”
BackgroundResultPrevious gestational diabetes history is associated with impaired coronary flow reserve
Çalışkan, M., Turan, Y., Çalışkan, Z., Güllü, H., Ciftci, F. C., Avcı, E., Duran, C., Köstek, O., Çaklılı, Ö. T., Koca, H., et al. (2015) · Annals of Medicine · doi:10.3109/07853890.2015.1099719 · Cited by 30
“GDM history apparently increases the progression of subclinical atherosclerosis, even in the absence of overt metabolic disease; therefore, a history of GDM may be considered to be a risk factor for atherosclerosis (20).”
BackgroundCersósimo, E., Xu, X., & Musi, N. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00022.2011 · Cited by 31
GLP-1–Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus
Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., Serné, E. H., & van Raalte, D. H. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307930 · Cited by 31
Viljanen, A. P. M., Virtanen, K. A., Järvisalo, M. J., Hällsten, K., Parkkola, R. K., Rönnemaa, T., Lönnqvist, F., Iozzo, P., Ferrannini, E., & Nuutila, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1073 · Cited by 32
Pontiroli, A. E., Pizzocri, P., Paroni, R. C., & Folli, F. B. (2006) · Diabetes Care · doi:10.2337/dc06-1417 · Cited by 31
Metadata
- Authors
- Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D.
- Affiliations
- Indiana University (US)
- Richard L. Roudebush VA Medical Center (US)
- Indiana University Hospital (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-06-01
- Volume
- 97
- Issue
- 11
- Pages
- 2601-2610
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507347
- OpenAlex
- W1982811953
- Cited by
- 1,687
- References
- 59
- Citations by year
- 2026: 11 · 2025: 23 · 2024: 17 · 2023: 30 · 2022: 19 · 2021: 32 · 2020: 30 · 2019: 36 · 2018: 36 · 2017: 46 · 2016: 50 · 2015: 51 · 2014: 69 · 2013: 69 · 2012: 61
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- American Heart Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42469, P60DK020542, DK20542)
- National Center for Research Resources (M 01-RR750-19)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- obesity, insulin resistance, endothelial dysfunction, endothelium-dependent vasodilation, euglycemic hyperinsulinemia, leg blood flow, methacholine, sodium nitroprusside, type 2 diabetes, fat mass, atherosclerosis risk
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Cholesterol, Diabetes Mellitus, Type 2, Endothelium, Vascular, Fatty Acids, Nonesterified, Glucose, Humans, Hyperinsulinism, Infusions, Intra-Arterial, Infusions, Intravenous, Insulin, Insulin Resistance, Leg, Cholesterol, HDL, Cholesterol, LDL, Nitroprusside, Obesity, Reference Values, Regional Blood Flow, Syndrome, Time Factors, Triglycerides, Vasodilation, Glucose Clamp Technique, Body Mass Index, Methacholine Chloride
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
